Randomized trial of fenretinide (4-HPR)
โ
Fausto Chiesa; Nicoletta Tradati; Roberto Grigolato; Patrizia Boracchi; Elia Big
๐
Article
๐
2005
๐
John Wiley and Sons
๐
French
โ 84 KB
## Abstract We assessed the efficacy of fenretinide at preventing relapses, new lesions and carcinomas after surgical excision of oral leukoplakia. In a controlled multicenter study, 170 patients operated on for oral leukoplakias with benign postoperative histology were randomized to 200 mg fenreti